Guggenheim raises target to USD 14.00 for Neogen stock

Published on 10/15/2026 at 20:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 6.50 percent year over year to USD 222.80 million in fiscal first quarter 2027. Neogen stock costs EUR 10.78 on October 15, 2026.

Analyst target and quarterly growth

Guggenheim raised its Neogen target from USD 12.00 to USD 14.00 on September 30, 2026.
Fiscal first-quarter revenue rose 6.50 percent year over year to USD 222.80 million.
Neogen stock costs EUR 10.78 at Lang & Schwarz on October 15, 2026 at 8:45 p.m. CEST.
Neogen is scheduled to report its next earnings on January 14, 2027.

NEOG, US6404911066, Illustration mit AI erstellt.

Guggenheim raised its Neogen target from USD 12.00 to USD 14.00 in a research report dated September 30, 2026, according to MarketBeat. Against the Nasdaq price of USD 12.11 on October 15, 2026 at 2:54 p.m. ET, the target stood 15.61 percent higher. At Lang & Schwarz, the euro quote was EUR 10.78 on October 15, 2026 at 8:45 p.m. CEST.

Revenue reaches USD 222.80 million

Neogen reported fiscal first-quarter revenue of USD 222.80 million for the three months ended August 31, 2026, up 6.50 percent from USD 209.20 million a year earlier. Adjusted earnings per share came to USD 0.08, compared with USD 0.04 in the prior-year quarter, while adjusted EBITDA reached USD 41.60 million and the adjusted EBITDA margin was 18.70 percent, according to BioSpace.

Stock stays below the yearly high

The Nasdaq quote of USD 12.11 was 15.08 percent below the 52-week high of USD 14.26 and 125.51 percent above the 52-week low of USD 5.37 on October 15, 2026. Trading volume was 1,429,019 shares against an average volume of 3,225,573 shares. The euro quote remained the relevant view for German investors, while the Nasdaq price supplies the home-market comparison.

Valuation and next reporting date

Neogen had a market capitalization of USD 2.6 billion and a negative price-to-earnings ratio of 47.79 on October 15, 2026. The company does not pay a dividend. Investing.com lists January 14, 2027 as the next earnings date.

Comparison with peers

NEOG: P/E minus 47.79, market capitalization USD 2.6 billion

Henry Schein (Nasdaq, USD): plus 1.52 percent, P/E 25.32, market capitalization USD 9.7 billion

DENTSPLY SIRONA (Nasdaq, USD): plus 3.84 percent, P/E minus 3.20, market capitalization USD 1.7 billion

Price remains the clearest daily signal

Neogen's quarterly growth and the higher analyst target provide two reference points, but the stock still trades below its annual high. The next scheduled earnings date is January 14, 2027, leaving execution and margin delivery as the main measurable milestones.

The further course of trading is shown by the continuously updated real-time quote of Neogen stock.